Related Experiment Video

Updated: Jun 11, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.0K

NLA Expert Clinical Consensus on apolipoprotein B recommends expanded clinical use and improved patient access

Kevin C Maki, P Barton Duell

    Journal of Clinical Lipidology
    |September 29, 2024
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Formulation and Characterization of Bioactive Agent Containing Nanodisks
    07:58

    Formulation and Characterization of Bioactive Agent Containing Nanodisks

    Published on: March 17, 2023

    1.0K
    Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
    12:40

    Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

    Published on: May 19, 2018

    10.2K

    Related Experiment Videos

    Last Updated: Jun 11, 2025

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
    06:47

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

    Published on: January 28, 2021

    11.0K
    Formulation and Characterization of Bioactive Agent Containing Nanodisks
    07:58

    Formulation and Characterization of Bioactive Agent Containing Nanodisks

    Published on: March 17, 2023

    1.0K
    Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
    12:40

    Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

    Published on: May 19, 2018

    10.2K

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    2
    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    2
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    581
    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    581

    Articles linked to this work by shared authors, journal, and citation graph.

    Dietary Interventions for Hypertriglyceridemia.

    Current atherosclerosis reports·2026

    JCL Roundtable: Rewriting the rules for primary prevention: New outcomes from intensive LDL-C reduction in high-risk patients.

    Journal of clinical lipidology·2026

    Association of Cancer Incidence and Cancer-Related Mortality with Statin Therapy, Ezetimibe, and Statin-Ezetimibe Combination - A Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.

    European journal of preventive cardiology·2026

    Effects of Dietary Protein Quantity, Source, and Type on Plasma Lipids and Lipoproteins and Their Roles in Dyslipidemia Management in Humans.

    Nutrients·2026

    Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide Study.

    JACC. Asia·2026

    Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid.

    Journal of the American Heart Association·2026

    The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients with ultrahigh-risk ASCVD.

    Journal of clinical lipidology·2026

    Sitosterolemia as a treatable and underrecognized cause of chronic thrombocytopenia beyond ITP: A targeted screening study.

    Journal of clinical lipidology·2026

    Retrospective analysis of serial lipoprotein(a) measurements in pediatric patients: Intraindividual variability and impact on risk stratification.

    Journal of clinical lipidology·2026

    Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry.

    Journal of clinical lipidology·2026

    TUDOR, an ascertainment-aware model for LDLR genetic-testing triage in specialist lipid clinics: Development, validation, and UK Biobank transport.

    Journal of clinical lipidology·2026

    Discordance between remnant cholesterol and small dense LDL cholesterol obscures interpretation of the results of the PROMINENT trial.

    Journal of clinical lipidology·2026

    Targeting Nonclassical Monocytes via Artificial Cell-Microneedles for Precision Psoriasis Therapy.

    Advanced materials (Deerfield Beach, Fla.)·2026

    Intranasal delivery of engineered macrophage-membrane-coated nanoparticles with enhanced Dectin-1 expression for targeted therapy of cryptococcal meningitis.

    Biomaterials·2026

    Trends in Meningioma Incidence, Treatment, and Imaging Surveillance.

    JAMA oncology·2026

    Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.

    JACC. Case reports·2026

    Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2.

    iScience·2026

    Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.

    Journal of vitreoretinal diseases·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us